Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Reprogramming CD4 t cells into cytotoxic CD8 cells by forced expression of CD8ab and class 1 restricted t cell receptors

Reprogramming CD4 t cells into cytotoxic CD8 cells by forced expression of CD8ab and class 1 restricted t cell receptors

US Patent 12377147 · Granted Aug 5, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD8 polypeptides, compositions, and methods of using thereof2025
Oncolytic virotherapy with helper-dependent adenoviral-based vectors expressing 2024
Histone deacetylase (HDAC) inhibitor up-regulates car expression and targeted an2023
Compositions and methods for the treatment of HER2-expressing solid tumors2022
Methods for inducing selective apoptosis2021
CD5 chimeric antigen receptor for adoptive T cell therapy2020
Oncolytic virotherapy and immunotherapy2020
Histone deacetylase (HDAC) inhibitor up-regulates car expression and targeted an2019
Immunotherapy of cancer using genetically engineered GD2-specific T cells2016
Methods for inducing selective apoptosis2016
Methods for inducing selective apoptosis2015
Gene therapy expression of GHRH for increasing RBC count in subjects2012